PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Dung T. Le(Johns Hopkins University), Luis A. Díaz(Memorial Sloan Kettering Cancer Center), Nathan Cuka(Johns Hopkins University), Bjarne R. Bartlett(State University of New York), Robert A. Anders(Johns Hopkins University), Andrew D. Skora(Howard Hughes Medical Institute), Janis M. Taube(Bloomberg (United States)), George A. Fisher(Stanford University), Nickolas Papadopoulos(Johns Hopkins University), Laura D. Wood(Johns Hopkins University), Dan Laheru(Johns Hopkins University), Steven M. Duffy(Johns Hopkins University), Jennifer N. Uram(Johns Hopkins University), Kenneth W. Kinzler(Johns Hopkins University), James R. Eshleman(Johns Hopkins University), Nilofer S. Azad(Johns Hopkins Hospital), Albert de la Chapelle(Université Claude Bernard Lyon 1), Feriyl Bhaijee(Johns Hopkins University), Drew M. Pardoll(Bloomberg (United States)), Bert Vogelstein(Johns Hopkins University), Atif Zaheer(Johns Hopkins University), Minori Koshiji(Eli Lilly (Japan)), Todd S. Crocenzi(Providence Portland Medical Center), Richard M. Goldberg(Ontario Institute for Cancer Research), Thomas Huebner(Johns Hopkins University), Holly Kemberling(Johns Hopkins University), Brandon Luber(Johns Hopkins University), Toby C. Cornish(Medical College of Wisconsin), Shibin Zhou(Johns Hopkins University), Hao Wang(University of Electronic Science and Technology of China), James J. Lee(UPMC Hillman Cancer Center), Aleksandra Eyring(Johns Hopkins University), Ralph H. Hruban(Johns Hopkins University), Ross C. Donehower(Unknown), Barbara Biedrzycki(Johns Hopkins University)
Cited by 9,425
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Cancer Genome Landscapes
|Science|2013|8k
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k